Skip to content

Lower-Cost Contingency Management in a Group Setting - 1

Lower-Cost Contingency Management in a Group Setting

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00249600
Enrollment
172
Registered
2005-11-07
Start date
2003-03-31
Completion date
2007-12-31
Last updated
2011-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Substance Abuse

Keywords

contingency management, substance abuse

Brief summary

The purpose of this study is to evaluate the efficacy of prize contingency management (CM) in enhancing attendance, reducing drug use, and improving health among clients attending two HIV drop-in centers. Specifically, 172 clients are randomly assigned to one of two 6-month treatment conditions: standard 12-step oriented group treatment, or CM group treatment. In the CM group, clients earn the chance to win prizes for submitting clean urine specimens and for complying with steps toward their treatment goals. Activities related to improving health will be emphasized, such as attending medical appointments, recording daily medication consumption, getting prescriptions filled, and attending medication adherence support groups. Group attendance, drug use, medical problems, services received, and risky drug use and sexual behaviors will be measured pre-treatment and at months 1, 3, 6, 9 and 12.

Interventions

BEHAVIORALContingency management

Sponsors

National Institute on Drug Abuse (NIDA)
CollaboratorNIH
UConn Health
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* HIV-positive and a member of The Living Center or the Manchester Area Network on AIDS * DSM-IV diagnosis of current opioid or cocaine abuse or dependence * willingness to accept random assignment to one of the two treatment groups

Exclusion criteria

* inability to comprehend the study (Mini-mental status score \<21; Folstein & Folstein, 1975; or inability to pass an informed consent quiz) * severely disruptive behavior * in recovery for pathological gambling (due to potential similarity between the CM procedure and gambling) * non-English speaking

Design outcomes

Primary

MeasureTime frame
Drug usebaseline and each follow-up

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026